Gilder Gagnon Howe & Co’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,006
Closed -$12K 403
2021
Q3
$12K Hold
1,006
﹤0.01% 400
2021
Q2
$21K Hold
1,006
﹤0.01% 388
2021
Q1
$28K Sell
1,006
-118
-10% -$3.28K ﹤0.01% 364
2020
Q4
$29K Sell
1,124
-4
-0.4% -$103 ﹤0.01% 318
2020
Q3
$42K Hold
1,128
﹤0.01% 318
2020
Q2
$58K Hold
1,128
﹤0.01% 290
2020
Q1
$36K Sell
1,128
-4
-0.4% -$128 ﹤0.01% 261
2019
Q4
$68K Hold
1,132
﹤0.01% 274
2019
Q3
$41K Hold
1,132
﹤0.01% 273
2019
Q2
$53K Hold
1,132
﹤0.01% 280
2019
Q1
$45K Sell
1,132
-468
-29% -$18.6K ﹤0.01% 268
2018
Q4
$74K Sell
1,600
-3
-0.2% -$139 ﹤0.01% 254
2018
Q3
$71K Sell
1,603
-71
-4% -$3.15K ﹤0.01% 276
2018
Q2
$66K Sell
1,674
-13
-0.8% -$513 ﹤0.01% 270
2018
Q1
$122K Sell
1,687
-2
-0.1% -$145 ﹤0.01% 270
2017
Q4
$111K Hold
1,689
﹤0.01% 279
2017
Q3
$85K Hold
1,689
﹤0.01% 266
2017
Q2
$78K Sell
1,689
-51
-3% -$2.36K ﹤0.01% 269
2017
Q1
$61K Sell
1,740
-13
-0.7% -$456 ﹤0.01% 264
2016
Q4
$22K Sell
1,753
-2,008
-53% -$25.2K ﹤0.01% 260
2016
Q3
$52K Sell
3,761
-69
-2% -$954 ﹤0.01% 258
2016
Q2
$38K Sell
3,830
-50
-1% -$496 ﹤0.01% 265
2016
Q1
$66K Sell
3,880
-203
-5% -$3.45K ﹤0.01% 218
2015
Q4
$91K Sell
4,083
-1,614
-28% -$36K ﹤0.01% 226
2015
Q3
$134K Sell
5,697
-814,008
-99% -$19.1M ﹤0.01% 228
2015
Q2
$67M Buy
819,705
+13,715
+2% +$1.12M 0.88% 37
2015
Q1
$74.6M Buy
805,990
+775,589
+2,551% +$71.8M 1.04% 30
2014
Q4
$1.23M Buy
+30,401
New +$1.23M 0.02% 196